Ono Pharmaceutical Q2 GAAP EPS of ¥95.60, revenue of ¥232.5B

What happened: Ono Pharmaceutical reported Q2 GAAP EPS of ¥95.60 and revenue of ¥232.5B, a 9.6% decline year on year. Key numbers: Q2 GAAP EPS ¥95.60; revenue ¥232.5B, down 9.6% Y/Y; six-month operating profit ¥57.91B, up 11.2% Y/Y; core operating profit ¥73.63B, up 5.1%; FY ending March 31, 2027 forecast revenue ¥455.00B and operating profit ¥94.00B on an IFRS basis. Why it matters: Revenue fell year on year while operating profit and core operating profit grew over the six-month period, and the company issued full-year forecasts on an IFRS basis. Coverage: 4 outlets in 24h

Ono Pharmaceutical reported Q2 GAAP EPS of ¥95.60 and revenue of ¥232.5B, a 9.6% decline year on year.

Revenue fell year on year while operating profit and core operating profit grew over the six-month period, and the company issued full-year forecasts on an IFRS basis.